The Design and Synthesis of Transition Metal Complexes Supported by Non-innocent Ligand Scaffolds for Small Molecule Activation by Horak, Kyle Tadashi
 
 
 
 
 
 
 
APPENDIX B 
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Abstract 
The synthesis of biomimetic model complexes of the full H-cluster of [FeFe]-
hydrogenase was targeted. Intended to be a more synthetically modular approach than 
that reported by the Pickett group, the [Fe4S4] cluster would be supported by short 
peptides of variable amino acid composition containing a conserved CX2CX2C motif. 
The incorporation of the diiron subsite would then be accomplished via thioester 
exchange with a specialized model complex shown to work in the literature. The 
synthesis of a variety of peptides was accomplished though the solubility of the 
sequences proved problematic for characterization. [Fe4S4] incorporation into a 
peptide containing the sequence NH2-GCIACGACGW-(CO)NH2 could be confirmed 
spectroscopically. However, subsequent addition of the diiron subsite mimic yielded 
unclear results. Furthermore, the correct binding of the diiron unit to the cluster could 
not be confirmed. Instead, evidence for peptide acetylation resulting from thioester 
exchange with polar residues side chains was observed. This unanticipated 
complication in subsite incorporation resulted in the discontinuation of the project. 
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INTRODUCTION 
As a fuel, molecular hydrogen is both carbon-neutral and renewable, if produced by solar-
driven electrolysis.1 Currently, steam reforming of hydrocarbons, primarily methane, is the 
dominant industrial method for hydrogen production.2 This process is both energy intensive 
and ultimately dependent on fossil fuels, making it an ineffectual method of producing 
hydrogen for use as an alternative fuel. Current electrolysis cells typically require precious 
metals, typically platinum,2 to function without high energetic penalties in the form of catalytic 
overpotentials. While inorganic materials such as molybdenum sulfide and phosphide have 
emerged recently as promising low overpotential electrocatalysts for hydrogen evolution, 
further research is required to continue to improve future devices.3 
 
Figure 1. Protein crystal structures of the three classes of hydrogenases. Figure adapted 
from Lubitz,W. Chem. Rev. 2014, 114, 4081-4148. 
Inspiration for suitable replacement proton reduction electrocatalysts can be found in 
nature. The hydrogenases are a family of enzymes capable of catalyzing the reversible 
interconversion of protons and electrons with molecular hydrogen.4 These enzymes operate 
at negligible overpotentials and undergo thousands of turnovers per second while using only 
the earth-abundant metals iron and nickel.4a Protein X-ray crystallography studies have 
structurally characterized the active sites of three distinct classes of hydrogenase enzymes: 
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[FeFe]-, [NiFe]-, and [Fe]-only hydrogenase (Figure 1), which each show diverse metallic 
content and active site structure.5 Biomimetic model complexes of each class of hydrogenase 
have sought to mimic the chemical properties and reactivity of their native enzymatic 
counterparts to better understand the biological systems and aid in the rational design of future 
electrocatalysts.4 The enzymatic active site inorganic cofactor of [FeFe]-hydrogenase, dubbed 
the H-cluster, consists of [Fe4S4] cluster linked to an unusual diiron subsite by a bridging 
cysteine ligand (Figure 2, Left). The diiron subsite itself possess multiple, biologically unusual 
carbon monoxide and cyanide ligands and an azadithiolate ligand which bridges the two iron 
centers in a butterfly conformation with both sulfur donors. While two model complexes have 
been reported that incorporate both a diiron subsite model and a tethered redox cofactor 
(Figure 2, Right), H-cluster mimics remain uncommon in the literature.6 Herein we discuss 
attempts to synthesize a six iron model complex of the H-cluster that utilizes and peptide to 
support a [Fe4S4] moiety that will be tethered to a diiron subsite mimic previously reported by 
Pickett and coworkers.6b 
 
Figure 2. Schematic representation of the [FeFe]-hydrogenase active site (Left), and 
synthetic model complexes mimicking both the diiron subsite and [Fe4S4] cluster 
(Right). 
RESULTS AND DISCUSSION 
Section B.1 Peptide Synthesis 
Scheme 1. General scheme for Fmoc-based solid phase peptide synthesis 
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9-fluorenylmethyloxycarbonyl-based (Fmoc) protection schemes were employed to 
produce tricysteine peptides on a rink amide resin using solid-phase peptide synthesis 
protocols (Figure 4).7 Subsequent cleavage from solid support using trifluoroacetic acid yielded 
C-terminally amidated, unpurified peptides on a multiple 100 mg scale. Sequences of the 
general form NH2-(X)iCIACGAC(X)j-CONH2 based on literature peptides were designed to 
include an internal CX2CX2C motif previously shown to bind [Fe4S4]-clusters (Table 1). (X)j 
sequences generally consisted of one to two glycine residues followed by a tryptophan to serve 
as a convenient UV/Vis (ε280nm = 5600 M-1cm-1) and 1H-NMR handle, while (X)i sequences 
were typically a single glycine. 
Unfortunately, the majority of peptides (1a-1i) synthesized possessed limited solubility 
making purification by reverse-phase high performance liquid chromatography (RP-HPLC) 
difficult (Table 1).  N-terminally acetylated peptides were virtually insoluble in all solvents 
except DMF and DMSO.  Ultimately, the literature peptide, 1h, was selected for preparatory-
scale RP-HPLC as it presented the highest solubility in aqueous-acetonitrile solvent systems 
and was known to efficiently bind [Fe4S4]-clusters.  The limited solubility of most of these 
peptides is likely a reflection of the cluster-binding environment in ferredoxin proteins, which 
are often buried in hydrophobic portions of the protein away from bulk solvent.  The identity 
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and purity of 1h was confirmed by electrospray ionization mass spectrometry (ESI-MS) and 
1H-NMR spectroscopy. 
Table 1. Compiled list of synthesized peptides.  ǂ Synthesized of glycine preloaded Wang resin. 
 
Section B.2 Attempted Assembly of Peptide-supported H-cluster Model Complexes 
To assemble the peptide-supported H-cluster, a synthetic strategy analogous to that 
reported for the synthesis of 6 was adopted (Scheme 2).6b Previous studies of peptide-
supported [Fe4S4]-clusters employed reconstitution protocols that took advantage of the 
CX2CX2C motif to self-assemble clusters from dissolved iron and sulfide salts under anaerobic 
conditions.8  Tetracysteine peptides demonstrated near complete reconstitution yields, while 
omission of a single cysteine typically showed diminished efficiencies of ~50%.9 To 
circumvent the reduced yields, use of a preformed cluster allowed for facile cluster binding via 
thiolate exchange.  Similar strategies were previously shown by Holm to achieve near 
quantitative cluster incorporation in peptides.10 
 
 
Peptide # N-term. (AA)n C-Term. Solubility
1aǂ p-F-aryl-C(O)- GCIACGWCGG -OH <10mg/mL in DMF or DMSO
1bǂ Acetyl- GCIACGWCGG -OH <10mg/mL in DMF or DMSO
1cǂ H- GCIACGACGG -OH <10mg/mL in DMF or DMSO
1d H- GCIACGWCGG -NH2 <10mg/mL in DMF or DMSO
1e H- CGGCGGC -NH2 ~20mg/mL MeCN:H2O
1f H- CGGCGGCW -NH2 <10mg/mL in DMF or DMSO
1g Acetyl- CGGCGGCW -NH2 <10mg/mL in DMF or DMSO
1h H- GCIACGACGW -NH2 ~20mg/mL MeCN:H2O
1i H- RGCIACGACGW -NH2 ~20mg/mL MeCN:H2O
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Scheme 2. Proposed synthetic scheme for the synthesis of a peptide supported H-cluster 
model complex 
 
Preformed [Fe4S4]-clusters have been extensively studied,11 and the benzyl thiolate and 
tetrabutylammonium variant, [Fe4S4(SBn)4][NBu4]2, was readily synthesized. Reaction of 1h 
with the preformed cluster produced a dark brown solid for which broadened 1H-NMR 
resonances could be observed and assigned to benzyl thiolate and peptide protons (Scheme 
3).  ESI-MS confirmed the formation of 2 which showed signals corresponding to [2]2- and [2-
(SBn)]2- ions.  Electron paramagnetic resonance (EPR) spectroscopy of samples of 2 showed 
no signal confirming negligible degradation of the [Fe4S4]2+ cluster to an EPR active [Fe3S4]+ 
species.  Furthermore, reduction with disodium dithionite produced 4 for which a rhombic, S 
= 1/2, EPR signal with g-values of 1.88, 1.93, and 2.06 was observed (Figure 3), in close 
agreement with literature values for ferredoxin proteins.12 An independently synthesized 
reduced [Fe4S4]-cluster precursor, [Fe4S4(SBn)4[NBu4]3, produced an axial EPR signature with 
g-values of 1.93 and 2.04, supporting intact cluster binding to 4.12  Reactions of the reduced 
cluster precursor with 1h directly yielded 4 without the use of chemical reductants (Figure 4). 
With the [Fe4S4]-cluster bound to 1h, incorporation of the diiron subsite was attempted.  
In literature reports a diiron subsite containing thiolate masked by an acetyl group was 
employed.6b Thioester exchange and subsequent loss of a carbon monoxide ligand formed the 
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μ2-thiolate to generate six Fe cluster and release the acetylated thiolate.  A similar approach 
was attempted for the peptide-bound compound 2.  Despite repeated attempts, reactions of 
the diiron subsite with 2 never showed evidence of formation of the target complex, 4.  ESI-
MS confirmed consumption of the diiron subsite complex, however only acetylated 2 and 
diiron decomposition products were detected (Scheme 4).  These data suggest quantitative 
acetylation of peptide side chains or N-terminus of 2 without displacement of the benzyl 
thiolate. 
Scheme 3. Synthesis of peptide-supported [Fe4S4] clusters 
 
EPR spectroscopy of reaction mixtures revealed an unusual feature centered around 3320 
G, which could not be attributed to known [Fe4S4]-cluster degradation products (Figure 5).  
Upon reduction with disodium dithionite, the signal typical of a [Fe4S4]+ cluster appeared 
(Figure 6), confirming the presence of an intact, peptide-bound cluster. 
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Scheme 4. Attempted incorporation of the diiron subsite to 4 
 
In theory, prior acetylation of the N-terminus of 1h should be sufficient to minimize side 
reactions with the diiron subsite complex.  However, the limited solubility of such a peptide 
would make RP-HPLC purification on reasonable scales challenging.  Future peptides, will 
include additional polar amino acids to improve solubility while avoiding of sites capable of 
competing with the thioester exchange required for diiron linkage to the [Fe4S4]-cluster. 
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Figure 3. EPR spectrum of 4 produced by the metalation of 1h with the reduced cluster 
precursor. 
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Figure 4. EPR spectrum of 4 produced by the reduction of 2 with dithionite. 
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Figure 5. EPR spectrum of the reaction of 2 with the diiron subsite model complex. 
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Figure 6. EPR spectrum of the reaction of 2 with the diiron subsite model complex following 
reduction with dithionite. 
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CONCLUSIONS 
In conclusion, attempts to synthesize peptide-supported H-cluster model 
complexes was attempted. Peptide syntheses were successfully accomplished utilizing 
Fmoc-based approaches, however sequence optimization was required to access 
peptides of sufficient solubility to properly characterize and utilize in reactions. 
Incorporation of preformed [Fe4S4] clusters into the peptides proved successful with 
degradation not observed by EPR or ESI-MS. Unfortunately, attempts construct the 
full six Fe cluster proved unsuccessful as acetylation of the peptide backbone was 
interfering with thioester exchange with the last thiolate ligand coordinated to the 
[Fe4S4] cluster. 
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EXPERIMENTAL SECTION 
General considerations.  
Unless otherwise specified, all compounds were manipulated in a glovebox under a 
nitrogen atmosphere.  Solvents for all reactions were dried by the Grubb's method. All 
purchased chemicals were used as ordered without further purification.  Fmoc-protected 
amino acids, solid-phase resins and coupling reagents were purchased from Advanced 
Chemtech.  Trifluoroacetic acid (TFA), triisopropyl silane (TIS), diisopropylethylamine 
(DIEA), and piperidine were purchased from Sigma Aldrich.  HPLC-grade acetonitrile was 
purchased from VWR International.  All deuterated NMR solvents were purchased from 
Cambridge Isotopes.  1H-NMR and 31P-NMR were recorded on a Varian 300 MHz with 
chemical shifts reported with respect to internal solvent at ambient temperatures unless 
otherwise noted.  Mass spectrometry data was obtained using the Caltech Institute of 
Technology Mass Spectrometry Facility ESI-MS instrument.  RP-HPLC was run on Agilent 
instruments utilizing a preparatory-scale C18 column. EPR experiments were run on an X-
band Bruker instrument at 1 mmolar concentrations and 10 K unless otherwise noted. Other 
EPR instrument settings include microwave frequency 9.378 GHz, microwave power 5.115 
mW, receiver gain 1.00e+003, modulation frequency 100 kHz, modulation amplitude 5.00 G, 
time constant 40.060 ms. Fe2(CO)6CH3C(CH2S)2CH2SCOCH3,6b [Fe4S4(SBn)4][NBu4]2,11a and 
[Fe4S4(SBn)4][NBu4]312 were synthesized according to literature procedures. 
 
Peptide synthesis and purification of Compound 1h 
Peptide synthesis of 1a-1i were done using identical methods. All peptide synthesis was 
done open to air using undried, reagent-grade solvents.  Peptide synthesis conditions were 
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adapted from literature protocols.18 Rink amide resin (850 mg, 0.5 mmol, 1 equiv) was added 
to a 50 mL peptide synthesis vessel (Chemglass, CG-1860-03) and swelled in ca. 40 mL of 
dichloromethane for 3 hours after which the solvent was removed by vacuum filtration.  The 
resin was then washed 3 times with ca. 30 mL of DMF.  Alternating Fmoc deprotection and 
amide coupling reactions were used to synthesize 1h by the stepwise addition of amino acids. 
Fmoc deprotection was deemed complete by Kaiser test with ca. 20 mL of 20% (v/v) 
piperidine in DMF agitated on a shaker for 25-30 minutes, and the resin was washed 3 times 
with ca. 30 mL DMF, then 3 times with ca. 30 mL of dichloromethane, then 3 times again with 
DMF.  For amide couplings, the Fmoc-protected amino acid (2 mmol, 4 equiv), 10 mL of 
freshly made 0.2 M solution of 1:1 HBTU:HOBt in DMF (2 mmol, 4 equiv), and 15 mL of a 
0.2 M DIEA solution in DMF (3 mmol, 6 equiv) were mixed and allowed to stand at room 
temperature for 2 minutes.  The activated amino acid was then transferred to the deprotected 
resin agitated on a shaker for 3 hours or until deemed complete by Kaiser test.  Excess 
unreacted coupling reagents and amino acids were removed by washing 3 times with ca. 30 mL 
DMF, then 3 times with ca. 30 mL of dichloromethane, then 3 times again with DMF.  
Following the final Fmoc deprotection, peptides were cleaved from the resin support with 20 
mL of a 95:2.5:2.5 TFA:TIS:H2O stirred for 3 hours.  A orange-yellow solution was collected 
by filtration and combined with TFA washes of the resin (ca. 10 mL) and the solvent removed 
in vacuo. The yellowish residue was triturated with 30 mL ether, then 3 times with 30 mL of 
hexanes, and then 3 more times with ether.  The resulting off-white powder was carried on to 
RP-HPLC purification.  Saturated solutions of crude 1h (ca. 15-20 mg/mL) in 1:1 MeCN:H2O 
acidified with 0.1% TFA were passed through 0.1 micron syringe filters (Pall Corporation).  2 
mL injections of 1h solution were separated on a preparatory-scale C18 column using a 
gradient from 0% solvent B-30% solvent B over 45 minutes at a flow rate of 20 mL/min, 
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where solvent A is 5:95 MeCN:H2O acidified with 0.1% TFA and solvent B is 95:5 
MeCN:H2O acidified with 0.1% TFA.  Fractions containing 1h were combined and lyophilized 
to yield a ca. 40 mg fluffy white powder in 8.5% overall yield.  1H-NMR (300 MHz, d6-DMSO) 
δ 10.77 (s, 1H, Trp(N-H)), 8.57 (d, 1H), 8.23 (t, 1H), 7.55 (d, 1H), 7.40 (s, 1H), 7.29 (d, 1H), 
6.53 (s, 1H), and multiple poorly resolved chemical shifts in both aliphatic and aromatic 
regions.  MS (m/z): calcd. 939.12 [M+H]+; found 939.2 [M+H]+, 961.5 [M+Na]+ (ESI-MS). 
 
Synthesis of Complex 2 
12h as the trifluoroacetate salt (10.0 mg, 9.5 μmol, 1 equiv) was stirred in 4 mL DMF for 
30 minutes then was transferred to solution of [Fe4S4(SBn)4][NBu4]2 (12.7 mg, 9.5 μmol, 1 
equiv) in 1 mL of DMF.  The resulting mixture was allowed to stir overnight at room 
temperature.  Aliquots of the reaction mixture were used for characterization.  1H-NMR (300 
MHz, d6-DMSO) δ 10.76 (broad, Trp(N-H)) and multiple, poorly resolved, broadened signals 
in both aliphatic and aromatic regions.  MS (m/z): calcd. 705.0 [M-2(NBu4)]2-; found 705.2 
[M-2(NBu4)]2-, 643.0 [M-SBn-2(NBu4)]2- (ESI-MS). 
 
Reduction of Complex 2 with Na2S2O4. 
500 μL of a freshly prepared 10 mmolar disodium dithionite solution in H2O (5 μmol, 5 
equiv) was added to a 500 μL aliquot of a 2 mmolar solution of 2 in DMF (1 μmol, 1 equiv).  
The mixture was stirred for 30 minutes before EPR aliquots were frozen.  EPR g-values (2.06, 
1.93, 1.88). 
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Synthesis of Complex 4 
Analogous protocol used for the synthesis of 2 with the addition of the reduced cluster 
precursor [Fe4S4(SBn)4][NBu4]3 (14.9 mg, 9.5 μmol, 1 equiv).  EPR g-values (2.04, 1.92, 1.88). 
MS (m/z): calcd. 705.0 [M-2(NBu4)]2-; found 705.2 [M-2(NBu4)]2-, 643.0 [M-SBn-2(NBu4)]2-, 
1652.2 [M-(NBu4)]- (ESI-MS). 
 
Reaction of Complex 2 with Fe2(CO)6CH3C(CH2S)2CH2SCOCH3. 
250 μL of a freshly prepared 2 mmolar solution of Fe2(CO)6CH3C(CH2S)2CH2SCOCH3 in 
DMF was added to 250 μL of a 2 mmolar solution of 2 in DMF. The mixture was stirred for 
30 minutes and aliquot was frozen for EPR.  5 equiv Na2S2O4 was added.  After stirring for 
an additional 30 minutes an aliquot was frozen for EPR. 
 
Reaction of Complex 4 with Fe2(CO)6CH3C(CH2S)2CH2SCOCH3. 
250 μL of a freshly prepared 2 mmolar solution of Fe2(CO)6CH3C(CH2S)2CH2SCOCH3 in 
DMF was added to 250 μL of a 2 mmolar solution of 2 in DMF. The mixture was stirred for 
30 minutes and aliquot was frozen for EPR.  5 equiv Na2S2O4 was added.  After stirring for 
an additional 30 minutes an aliquot was frozen for EPR.  
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